Outcome LMWH (Enoxaparin) Oral Anti-coagulant (Dabigatranetexalate/Apixaban) absolute risk difference  P Value Primary Efficacy outcome 7(50 patients) 8(50 patients) -1.1 <0.0001 Death 0 0 - - Safety outcome major bleeding 2 1 - 0.04

Table 2: efficacy & safety outcome